Anastasia Henry

Anastasia Henry is a Senior Director and Staff Scientist at Denali Therapeutics, where experience spans from August 2015 to the present, holding various leadership roles. Previously, Anastasia served as a Postdoctoral Fellow at Pfizer from January 2013 to August 2015 and as a Graduate Student Researcher at UCSF from September 2006 to October 2012, focusing on the role of ubiquitination in the trafficking of opioid receptors. Earlier research included studying endocrine regulation of pheromone production in bark beetles as an Undergraduate Student Researcher at the University of Nevada Reno. Anastasia holds a PhD in Cell Biology from the University of California, San Francisco, and a BS in Biochemistry from the University of Nevada, Reno.